Anteris Technologies and v2vmedtech Celebrate Milestone Achievement with VClip™ Repair System
Monday, 1 July 2024, 06:40
Anteris Technologies and v2vmedtech Update
Anteris Technologies and v2vmedtech have announced a major milestone in their joint development efforts with the successful completion of an animal study.
VClip™ Repair System Advancement
The study confirms the efficacy of the next-generation Mitral and Tricuspid Repair System, named VClip™, in addressing cardiac conditions.
Key Points:
- Successful completion of animal study
- Potential breakthrough in cardiac repair
- Innovation for cardiovascular treatment
This achievement signals a positive outlook for patients requiring advanced cardiac interventions, showcasing the commitment to excellence by both companies in delivering cutting-edge solutions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.